{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-036378","form_type":"8-K","ticker":null,"cik":"0001603207","company_name":"Notable Labs, Ltd.","filed_at":"2024-09-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.728491+00:00","generated_at":"2026-05-31T04:36:40.784870+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Notable Labs appoints Kaile Zagger as Interim CEO and Chief Restructuring Officer","bullets":["Kaile Zagger appointed Interim CEO and CRO, effective September 16, 2024.","Dr. Joseph Wagner steps down as interim CEO but remains Chief Scientific Officer.","Zagger is Managing Director at Province, LLC; services provided at $900/hour.","Zagger has over 20 years healthcare experience, including distressed turnarounds."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-036378","json":"https://secwatch.observer/filing/0001493152-24-036378.json","markdown":"https://secwatch.observer/filing/0001493152-24-036378.md","text":"https://secwatch.observer/filing/0001493152-24-036378.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1603207/000149315224036378/0001493152-24-036378-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1603207/000149315224036378/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T04:36:40.784870+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"964b46ea6a","claim":"Kaile A. Zagger was appointed as Interim Chief Executive Officer and Chief Restructuring Officer at Notable Labs, Ltd..","evidence_excerpt":"On September 16, 2024, Notable Labs, Ltd. (the “Company” or “Notable”) appointed Kaile A. Zagger as its Interim Chief Executive Officer and Chief Restructuring Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1603207/000149315224036378/0001493152-24-036378-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer and Chief Restructuring Officer"}],"fact_type":"executive_change"},{"claim_id":"f8278c3a7f","claim":"Joseph Wagner changed role as Chief Scientific Officer at Notable Labs, Ltd..","evidence_excerpt":"Effective September 16, 2024, Dr. Joseph Wagner, the Company’s Chief Scientific Officer, who was also acting as Chief Executive Officer on an interim basis, stepped down from his position as interim Chief Executive Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1603207/000149315224036378/0001493152-24-036378-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"Chief Scientific Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}